Newsletter Subject

Lululemon Founder’s Personal Longevity Investment Mission

From

longr.io

Email Address

hello@reads.longr.io

Sent On

Wed, Oct 25, 2023 12:12 AM

Email Preheader Text

Your daily digest on longevity investment, science and lifestyle ͏  ͏  ͏ ?

Your daily digest on longevity investment, science and lifestyle ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ October 24th, 2023 | [Read Online]( Join us at the premier longevity event, held in Miami from November 9th-11th. Use the link below to receive a 20% discount on tickets. Good Morning , Welcome to this week's exploration of the financial engines driving longevity advancements worldwide. From Lululemon's founder Chip Wilson leveraging his resources against a rare muscle ailment to the expansive investment vistas revealed by the rising global elderly population and Saudi Arabia's multi-billion-dollar bet on prolonging life—this digest offers a panoramic view of how deep pockets and high hopes are intertwined in the longevity landscape. As we traverse these narratives, we'll delve into the ambitions, endeavors, and innovations that spotlight the future of health and longevity investments. Let's get started... EVERY TUESDAY Eternal Equity Lululemon Founder’s Longevity Fight Chip Wilson, renowned founder of Lululemon, is channeling $100 million from his substantial fortune into conquering a rare muscle-wasting disease he's battled for decades. Diagnosed in 1987 with the uncommon facioscapulohumeral muscular dystrophy (FSHD2) variant, which afflicts a mere 43,000 globally, Wilson has faced progressive muscle loss. Fast forward to 2022, and he established the philanthropic venture, Solve FSHD, striving to unearth a cure by 2027. Already, $31 million has been invested in pioneering biotech solutions, emphasizing therapies for FSHD2. Simultaneously, Wilson pursues alternative treatments, including electroacupuncture and specialized enzyme IV drips. His conviction? Wealthy entrepreneurs, leveraging their vast resources and a results-driven approach, can accelerate medical breakthroughs in ways that traditional entities might not. [Business Insider]( Major players like Mark Zuckerberg, who is exploring optimized sleep, and Bryan Johnson, whose whole life is an ongoing experiment with longevity therapeutics, are pushing the envelope of what is possible today. A Broad Investment Opportunity, Longevity Longevity's surge in the global population offers fresh investment horizons, according to Dr. Damien Ng of Next Gen Insights. With the global populace predicted to hit 9.7 billion by 2050 and a significant increase in those aged 65 and above, sectors like leisure and wellness, beauty, elder care, nutrition, and financial planning are poised for growth. Notably, 85% of U.S. adults over 50 earmark travel as their top discretionary spend. While the beauty industry flourishes at an impressive $420 billion, the cruise sector witnesses a resurgence, especially among older patrons. Despite short-term challenges like inflation and drug pricing, the aging demographic paves the way for expansive investment opportunities in diverse sectors. [Julius Baer]( The round was led by Andreessen Horowitz and another mystery U.S. life-sciences investor. Big names like Fidelity Management & Research Co., BlackRock, and Nvidia's NVentures have also jumped on board. Saudi Arabia: The Ever-Flowing Tap of Longevity Funds? During a visit to Saudi Arabia in 2022, Alex Zhavoronkov, PhD, was struck by the nation's transformation.. Part of this change is Crown Prince Mohammed bin Salman's vision of enhancing longevity in the Kingdom as a national priority. An essential player in this journey is the Hevolution Foundation, backed with up to $1 billion annually from the Saudi government. Dedicated to aging research and therapies, the foundation's leadership includes Dr. Mehmood Khan, former Vice Chairman of PepsiCo, and longevity biotech expert, and Dr. Felipe Sierra, a key figure in the aging biology realm. With Saudi Vision 2030 emphasizing healthcare, AI, and education, the Kingdom's push into longevity research could lead to transformative outcomes for global health. [Forbes]( Brainchild of the entrepreneur Naveen Jain and backed by the glitz of Paris Hilton as both investor and brand ambassador, Viome is making waves with at-home kits that dive deep into stool samples, dishing out dietary insights, supplements, and probiotics. In this week's exploration, we've observed how both personal ambition and national visions can profoundly influence the longevity landscape. From individuals leveraging wealth to combat specific health challenges, to broad market opportunities shaped by shifting global demographics, and nations channeling vast resources to position longevity at the forefront—it's clear that the fusion of finance, innovation, and commitment holds transformative promise for the future of health and wellness. As the longevity sector continues to evolve, these diverse catalysts serve as a testament to its boundless potential. Until our next journey, The Longr Reads Team. "Someone's sitting in the shade today because someone planted a tree a long time ago." Warren Buffett, Investor Longr Reads' of the Week - Andrew Huberman Lab Podcast w/ Dr Peter Attia ([Youtube]( - Some claim human lifespans can be lengthened indefinitely ([The Economist]( - Longevity Clinics: What They Are, Services & More ([Spannr]( Longr is building access to longevity across: generative AI, therapeutics, wellness products, clinics, research, community, and marketplaces. Transforming visionary concepts into tangible solutions - we are facilitating widespread adoption of longevity-enhancing products and platforms. [Advertise with us](mailto:partnerships@longr.io) // [Book a call with Longr](mailto:ir@longr.io) 107 North Orange Street, Wilmington, Delaware 19801, United States You received this email from Longr Reads. If you would like to unsubscribe, [click here](.

Marketing emails from longr.io

View More
Sent On

09/06/2024

Sent On

05/06/2024

Sent On

04/06/2024

Sent On

03/06/2024

Sent On

31/05/2024

Sent On

30/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.